Advisory Committee on Immunization Practices (ACIP), 41985-41986 [2020-15178]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control (BSC, NCIPC). This meeting
is partially open to the public. There
will be 15 minutes allotted for public
comments at the end of the open session
from 12:30 p.m. to 12:45 p.m. on August
20, 2020.
DATES: The meeting will be held on
August 20, 2020, from 10:00 a.m. to 1:00
p.m., EST (OPEN) and August 20, 2020,
from 1:30 p.m. to 5:00 p.m., EST
(CLOSED).
SUMMARY:
Teleconference 1–800–369–
3110; Participant Code 7563795
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting as designated above will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
jbell on DSKJLSW7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
regarding policies, strategies, objectives,
and priorities; reviews progress toward
injury prevention goals; and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, and the structure, progress and
performance of intramural programs.
The Board is designed to provide
guidance on extramural scientific
program matters, including the: (1)
Review of extramural research concepts
for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to funding opportunity
announcements as they relate to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals.
Matters to be Considered: The open
portion of the agenda will include
discussions on Health Equity, Violence,
and Racism. All presentations will be
followed by discussion by the BSC.
The closed portion of the agenda will
focus on the Secondary Peer Review of
extramural research grant applications
received in response to three (3) Notice
of Funding Opportunities (NOFOs):
RFA–CE–20–002—‘‘Grants to Support
New Investigators in Conducting
Research Related to Preventing
Interpersonal Violence Impacting
Children and Youth’’; RFA–CE–20–
005—‘‘Rigorously Evaluating
Approaches to Prevent AdultPerpetrated Child Sex Abuse (CSA)’’;
and RFA–CE–20–006—‘‘Research
Grants to Prevent Firearm-Related
Violence and Injuries (R01)’’, as well as
PA–19–272/273–PHS 2019–02
‘‘Omnibus Solicitation of the NIH, CDC,
and FDA for Small Business Innovation
Research Grant Applications’’ (Parent
SBIR [R43/R44]). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
41985
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15029 Filed 7–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0081]
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Committee on
Immunization Practices (ACIP). This
meeting is open to the public. Time will
be available for public comment. The
meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on July
29, 2020, from 10 a.m. to 4 p.m., EDT
(times subject to change).
Written comments must be received
on or before July 30, 2020.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified
by Docket No. CDC–2020–0081, by
either of the following methods below.
CDC does not accept comment by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0081,
c/o Attn: July ACIP Meeting, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H24–8, Atlanta,
GA 30329–4027.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
SUMMARY:
E:\FR\FM\13JYN1.SGM
13JYN1
41986
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road,
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on COVID–19
vaccines. No recommendation votes are
scheduled. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
jbell on DSKJLSW7X2PROD with NOTICES
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Comments received are part of the
public record and are subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
all comments submitted into the docket.
CDC does not accept comment by email.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the July ACIP
meeting must submit a request at https://
www.cdc.gov/vaccines/acip/meetings/
no later than 11:59 p.m., EDT, July 22,
2020 according to the instructions
provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by July 23, 2020. To accommodate the
significant interest in participation in
the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: Written
comments must be received on or before
July 30, 2020. Written public comments
submitted by 72 hours prior to the ACIP
meeting will be provided to ACIP
members before the meeting.
This notice is being published less
than 15 days prior to the meeting due
to the public health emergency declared
on January 27, 2020. There is a critical
need for this committee to discuss
urgent matters related to discussions on
COVID–19 vaccines and be actively
engaged in the national response efforts
as dictated by circumstances and events.
In the interest of promoting openness
and transparency, we are publishing a
late notice in the Federal Register to
inform the public.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15178 Filed 7–9–20; 3:00 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0077]; [Docket No.
NIOSH 338]
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The audio
conference line has 150 ports for callers.
The public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference (information
below).
SUMMARY:
The meeting will be held on
August 26, 2020 from 1:15 p.m. to 6:15
p.m., EDT and August 27, 2020 from
1:15 p.m. to 6:30 p.m., EDT. An oral
public comment session will be held on
August 26, 2020 at 5:15 p.m. and
conclude at 6:15 p.m., or following the
final call for public comment,
whichever comes first.
Written comments must be received
on or before August 21, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0077, Docket No. NIOSH–338 by either
of the following methods listed below.
CDC does not accept comment by email.
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0077,
Docket number NIOSH–338 c/o Sherri
Diana, NIOSH Docket Office, National
Institute for Occupational Safety and
DATES:
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 85, Number 134 (Monday, July 13, 2020)]
[Notices]
[Pages 41985-41986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0081]
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
CDC, announces the following meeting of the Advisory Committee on
Immunization Practices (ACIP). This meeting is open to the public. Time
will be available for public comment. The meeting will be webcast live
via the World Wide Web.
DATES: The meeting will be held on July 29, 2020, from 10 a.m. to 4
p.m., EDT (times subject to change).
Written comments must be received on or before July 30, 2020.
ADDRESSES: For more information on ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/.
You may submit comments, identified by Docket No. CDC-2020-0081, by
either of the following methods below. CDC does not accept comment by
email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Docket No. CDC-2020-0081, c/o Attn: July ACIP
Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H24-8, Atlanta, GA 30329-4027.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
[[Page 41986]]
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters To Be Considered: The agenda will include discussions on
COVID-19 vaccines. No recommendation votes are scheduled. Agenda items
are subject to change as priorities dictate. For more information on
the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web; for more information on ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Comments received
are part of the public record and are subject to public disclosure. Do
not include any information in your comment or supporting materials
that you consider confidential or inappropriate for public disclosure.
If you include your name, contact information, or other information
that identifies you in the body of your comments, that information will
be on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket. CDC does not accept comment by email.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the July ACIP meeting must submit a request
at https://www.cdc.gov/vaccines/acip/meetings/ no later than 11:59 p.m.,
EDT, July 22, 2020 according to the instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by July 23, 2020. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: Written comments must be received on or
before July 30, 2020. Written public comments submitted by 72 hours
prior to the ACIP meeting will be provided to ACIP members before the
meeting.
This notice is being published less than 15 days prior to the
meeting due to the public health emergency declared on January 27,
2020. There is a critical need for this committee to discuss urgent
matters related to discussions on COVID-19 vaccines and be actively
engaged in the national response efforts as dictated by circumstances
and events. In the interest of promoting openness and transparency, we
are publishing a late notice in the Federal Register to inform the
public.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15178 Filed 7-9-20; 3:00 pm]
BILLING CODE 4163-18-P
